Skip to main content
LGVN
NASDAQ Life Sciences

Longeveron Finalizes Resale of 30.8M Shares, Enabling Massive Dilution from Deeply Discounted Private Placement

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$1.13
Mkt Cap
$25.595M
52W Low
$0.475
52W High
$1.83
Market data snapshot near publication time

Summary

Longeveron Inc. has filed a final prospectus enabling selling stockholders to resell 30.8 million shares, representing over 140% potential dilution, primarily from a recent deeply discounted private placement, with the company receiving no proceeds from these sales.


Key Events

  • Finalizes Resale of 30.8M Shares

    This prospectus enables selling stockholders to dispose of 30,865,385 shares of Class A common stock, formalizing the offering registered in the S-1 on April 10, 2026.

  • Massive Potential Dilution

    The shares available for resale represent over 140% potential dilution to the current Class A common stock outstanding, creating significant selling pressure.

  • No Proceeds to Company

    Longeveron will not receive any proceeds from the sale of these shares by the selling stockholders, except for a minor amount (up to $1.3M) from potential warrant exercises.

  • Origin from Deeply Discounted Private Placement

    The shares were primarily issued in a private placement at $0.52 per share, significantly below the current market price of $1.13.


Analysis

This 424B3 filing finalizes the registration for resale of 30.8 million shares by selling stockholders, making these shares immediately available for sale on the open market. This follows the S-1 registration filed on April 10, 2026, and operationalizes the significant dilution previously disclosed. The shares originate from a private placement at a deeply discounted price of $0.52 per share (compared to the current stock price of $1.13), as well as convertible preferred stock and placement agent warrants. The potential issuance and sale of these shares represent a massive potential dilution of over 140% relative to current outstanding Class A common stock. This event introduces substantial selling pressure on the stock, especially for a company already facing "substantial doubt about its ability to continue as a going concern" and Nasdaq delisting risks due to its low share price. The company will not receive any proceeds from these sales, except for a minor amount if placement agent warrants are exercised for cash. Investors should anticipate significant downward pressure on the stock price as these shares become available for disposition.

At the time of this filing, LGVN was trading at $1.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $25.6M. The 52-week trading range was $0.48 to $1.83. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LGVN - Latest Insights

LGVN
Jun 09, 2026, 9:20 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7855
Real-time Price: $0.7826 info
Change: -$0.0029 (-0.37%) info
Market Cap: $24.756M info
LGVN
Jun 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.730
Real-time Price: $0.7826 info
Change: +$0.0526 (+7%) info
Market Cap: $24.756M info
LGVN
May 20, 2026, 4:11 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $0.780
Real-time Price: $0.7826 info
Change: +$0.0026 (+0.33%) info
Market Cap: $24.756M info
LGVN
May 20, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.780
Real-time Price: $0.7826 info
Change: +$0.0026 (+0.33%) info
Market Cap: $24.756M info
LGVN
May 13, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.7697
Real-time Price: $0.7826 info
Change: +$0.0129 (+2%) info
Market Cap: $24.756M info
LGVN
May 08, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.834
Real-time Price: $0.7826 info
Change: -$0.0514 (-6%) info
Market Cap: $24.756M info
LGVN
May 08, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.7651
Real-time Price: $0.7826 info
Change: +$0.0175 (+2%) info
Market Cap: $24.756M info
LGVN
May 05, 2026, 5:42 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.8561
Real-time Price: $0.7826 info
Change: -$0.0735 (-9%) info
Market Cap: $24.756M info
LGVN
Apr 17, 2026, 4:23 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.13
Real-time Price: $0.7826 info
Change: -$0.3474 (-31%) info
Market Cap: $24.756M info
LGVN
Apr 10, 2026, 4:55 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $0.7826 info
Change: -$0.3378 (-30%) info
Market Cap: $24.756M info